What Ob-Gyns Think About the First Libido-Boosting Pill Approved for Use After Menopause
Self Magazine | 18.12.2025 05:06
Up until now, women who’d surpassed menopause and were dealing with frustratingly low libido—a.k.a. hypoactive sexual desire disorder (HSDD)—had no dedicated treatment option available to them. But that changed on December 15, 2025, when the FDA expanded its approval for the prescription drug Addyi (flibanserin), which was approved in 2015 to treat HSDD in premenopausal women, to also encompass postmenopausal women under age 65.
